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Background: Atopy is considered to be a complex genetic trait and does not follow a simple mendelian
pattern of inheritance. It is now well recognised that gene–gene interactions are important in complex genetic
disease.
Aim: To analyse the influence of gene–gene interactions in the development of atopy.
Methods: A total of 2055 ethnically identical participants aged 10–18 years living in rural areas on Jeju
Island, Korea, were randomly recruited. Atopy was defined as a positive skin prick test response to one or
more common inhalant allergens. Gene–gene interactions among 12 polymorphic loci were analysed in the
seven candidate genes of atopy using the multidimensionality-reduction method.
Results: A significant interaction was found between V297I in the gene coding vascular endothelial growth
factor receptor 2 (KDR) and 2308GRA in the gene coding tumour necrosis factor (TNF)a on the risk of
atopy, with a cross-validation consistency of 10 out of 10 and a prediction error of 35.9% (p = 0.001).
Conventional logistic regression also revealed significant interactions between KDR and TNF for atopy.
Individuals with the variant allele of 2308GRA in TNF (GA or AA) and V297I in KDR (VI or II) had a
significantly higher risk of atopy (OR 2.23; 95% CI 1.48 to 3.57).
Conclusion: KDR and TNF may synergistically influence the development of atopy through gene–gene
interaction in Korean children and adolescents.
A
topy is defined as a genetic predisposition to induce
enhanced IgE responses to common environmental
allergens. It is considered to be a complex genetic trait
and thus does not follow a simple mendelian pattern of
inheritance. Instead, the genetic determination of atopy is
probably due to several genes, each having a small, possibly
synergistic, effect on the phenotype. Therefore, it is necessary to
consider simultaneously the effect of several single-nucleotide
polymorphism (SNP) genotypes at different loci. Such gene–
gene interactions are traditionally evaluated using logistic
regression. However, procedures for fitting logistic regression
models are problematic, leading to an increase in type II errors
and a decrease in power. In addition, sparseness of the data can
be another problem in high dimensions.
To deal with these problems, multifactor-dimensionality
reduction (MDR) has been developed.1 MDR is a non-
parametric and genetic model-free approach and is able to
identify evidence for high-order gene–gene interactions in the
absence of any statistically significant independent main effects
in simulated data.2 3 With MDR, gene–gene interactions have
been revealed in complex genetic disorders such as hyperten-
sion,4 type 2 diabetes mellitus,5 atrial fibrillation,6 myocardial
infarction7 and asthma.8
In this study, 12 loci in seven genes proved to be related with
atopy or enhanced serum IgE were genotyped in Korean
children and adolescents, and gene–gene interaction was
examined with MDR.
METHODS
Study participants and atopy definit ion
All the participants enrolled in this study gave written informed
consent, and the study protocol was approved by the institu-
tional review board of Seoul National University Hospital,
Seoul, Republic of Korea. A total of 2864 ethnically identical
participants aged 10–18 years were randomly recruited through
schools located on the southern part of Jeju Island in Korea, of
whom 2055 (71.8%) were enrolled in this study. All of them
resided in rural areas, and most of their parents lived by fishing
or cultivating fruit trees. Skin prick testing with 11 common
aeroallergens (Dermatophagoides pteronyssinus, D farinae, dog fur,
cat fur, Aspergillus, Alternaria, tree pollen mixture, grass pollen
mixture, mugwort, ragweed and cockroach; Allergopharma,
Reinbeck, Germany) was performed as described previously.9
Participants who had received oral antihistamines during the
5 days before the skin prick test or had dermographism were
excluded. Atopy was defined as a positive skin prick test
response (allergen/histamine ratio .1 and a mean weal size
.4 mm) to one or more allergens.
Selection of genes and SNPs
On the assumption that cytokines play a crucial role in the
widely used immunological model that explains the increasing
prevalence of atopy by an altered balance between T helper (Th)
1 and Th 2 immune responses,10 we selected six cytokine-
related candidate genes using public databases—for example,
PubMed and Online Mendelian Inheritance in Man (http://
www.ncbi.nlm.nih.gov/Omim/). These have been characterised
and potentially associated with atopy or enhanced serum IgE in
an Asian population, and subsequent studies performed in a
non-Asian population have witnessed this association.11–25 The
only exception was kinase insert domain-containing receptor
(KDR) coding vascular endothelial growth factor (VEGF)
receptor 2 which, in our previous study, was proved to be
associated with an increased prevalence of atopy in a Korean
population.26 In addition to these cytokine-related genes, MS4A2
Abbreviations: KDR, kinase insert domain-containing receptor; MDR,
multifactor-dimensionality reduction; SNP, single-nucleotide
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coding high-affinity IgE receptor b subunit (FceR1B) was
included, which was also known to be distinctively associated
with atopy.27 28 Within these genes, 10 functional
SNPs11 12 14 17 18 29–31 were chosen for analysis. As for KDR,
I297V and H472Q were selected because they were located in
regions coding for the extracellular fourth and fifth immuno-
globulin-like domains and thus possibly alter the signalling
pathway as discussed in our previous study.26 Table 1 shows the
list of SNPs analysed in this study.
Genotyping
SNPs were scored using the high-throughput single base-pair
extension method (SNP-IT assay) using an SNPstream25K
system, which was customised to automatically genotype DNA
samples in 384-well plates and provide a colorimetric readout
(Orchid Biosciences, New Jersey, USA) as described pre-
viously.26
Statistical analysis
Allele frequencies were estimated by gene counting methods
and the x2 test was used to examine the Hardy–Weinberg
equilibrium. Association between atopy and each of the 12 loci
was made with the Pearson x2 test using dominant, recessive
and codominant genetic models. MDR (V.0.6.2; Computational
Genetics Laboratory, Dartmouth Medical School, Hanover, New
Hampshire, USA; http://www.epistasis.org) was performed as
described previously.1–3 5 8 The dataset is divided into 10 parts of
equal size for 10-fold cross-validation (9/10 of the data for
training and 1/10 of the data for testing). Next, a set of n SNP
polymorphisms is selected that are represented in n-dimen-
sional space. The ratio of cases to controls is then calculated for
each combination, which is labelled ‘‘high risk’’ (.1) or ‘‘low
risk’’ (,1). Consequently, n dimensional space was reduced to
one dimension with two levels. Among all of the two-factor
combinations, a single model that minimises classification error
is chosen. To evaluate the predictive ability of the model, a
prediction error is obtained through 10-fold cross-validation. In
our study we set out to detect all two-locus interactions
through five-locus interactions due to computation restrictions.
From this set, the model with the combination of loci that
maximises the cross-validation consistency and minimises the
prediction error is selected. We determined the statistical
significance of the final best model using 1000 permutation
testings. The entire procedure is repeated for each, generating a
distribution of predictive errors and cross-validation consis-
tencies that could be expected by chance alone. The significance
of the final model is determined by comparing the predictive
error and cross-validation consistency of the final model to the
distribution. A p value is extracted for the model by its
theoretical location in the distribution. In addition, logistic
regression analysis and x2 tests were performed to confirm the
results from MDR analyses. A p value ,0.05 was considered
significant. The detection power of the sample in this study was
0.8 for atopy, if the relative risk for atopy in people carrying a
putative risk allele is set to 2 compared with that in people




A total of 2055 children and adolescents were enrolled. The
mean age was 14.6 (range 10–18) years and 48.9% were male.
Table 2 shows the characteristics of the study population.
Association between atopy and individual SNPs
All 12 SNPs examined were in Hardy–Weinberg equilibrium.
The minor allele frequencies of SNPs in this study in
comparison with those previously reported are given in table
S1 (available at http://thorax.bmj.com/supplemental). Among
them, MS4A2 E237G (p = 0.028 in a codominant model), TNF
2308GRA (p = 0.031; odds ratio (OR) 1.31; 95% CI 1.02 to 1.69
in a dominant model) and KDR V297I (p = 0.048; OR 1.22; 95%
CI 1 to 1.5 in a dominant model) showed significant
associations with atopy (table 3).
MDR analysis
Table 4 summarises for each number of loci evaluated the
average cross-validation consistency and average prediction
error obtained from MDR analysis. A two-locus model had a
minimum prediction error of 35.93% (p = 0.001) and a
maximum cross-validation consistency of 10 out of 10. This
two-locus model, which included TNF 2308GRA and KDR
V297I (fig 1), was regarded as the best model.
Logistic regression analysis
A significant interaction between TNF 2308GRA and KDR
V297I on the risk of atopy was also found by means of logistic
regression analysis (p,0.001), adjusting for age, sex, passive
smoking and family history of allergic disease as covariates.
Individuals with the variant allele of TNF 2308GRA (GA or
AA) and KDR V297I (VI or II) had a significantly higher risk of
atopy (OR 2.3; 95% CI 1.48 to 3.57). Table 5 shows the results.
DISCUSSION
Perhaps the toughest problem faced by the allergist is that of
identifying genes carrying alleles affecting liability to asthma or
atopy from the vast field of potential candidates. The problem
becomes even harder if gene–gene interactions must be
considered. In this study, a two-locus model involving SNPs
Table 1 Candidate genes and single-nucleotide
polymorphism analysed in this study
Gene SNP rs Number Association
IL4R 23223TRC rs2057768 Atopy,11–13 IgE14
Q576R rs1801275
I75V rs1805010
IL13 21510ARC rs1881457 Atopy,16 17 IgE15 18
21111CRT rs1800925
R130Q rs20541
TNF 2308GRA rs1800629 Atopy,19 20 IgE21
IL12B S226N — Atopy22 23
IL12RB1 M365T rs375947 Atopy24 25
KDR* V297I rs2305948 Atopy26
H472Q rs1870377
MS4A2 E237G rs569108 Atopy,27 28 IgE27 28
SNP, single-nucleotide polymorphism; rs, reference SNP.
*KDR: gene coding vascular growth factor receptor 2.
MS4A2: gene coding high-affinity IgE receptor b subunit.
Table 2 Characteristics of study population
Characteristics Number of positivity, n (%)
Mean (range) age (years) 14.6 (10–18)
Male 1004 (48.9)
Atopy* 767 (37.3)
History of passive smoking 1342 (65.3)
Family history of allergic disease 376 (18.3)
Vaccination history 1552 (75.5)
*Positive skin test responses to one or more common aeroallergens.
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in TNF and KDR was identified by MDR as being associated
with atopy. Moreover, this was confirmed again by conven-
tional logistic regression analysis.
To date, several investigators have witnessed gene–gene
interactions in asthma or its related phenotypes using tradi-
tional procedures for fitting logistic regression models.15 32







Atopy 278 (38%) 346 (47.3%) 108 (14.7%) 0.13 0.413 0.301
Control 515 (41.4%) 561 (45.1%) 167 (13.5%)
Q576R
QQ QR RR
Atopy 529 (69.2%) 214 (28%) 21 (2.8%) 0.831 0.426 0.728
Control 890 (69.1%) 357 (27.7%) 41 (3.2%)
V75I
VV VI II
Atopy 244 (31.9%) 378 (49.5%) 142 (18.6%) 0.789 0.283 0.214




Atopy 381 (53.4%) 267 (37.5%) 65 (9.1%) 0.63 0.17 0.248
Control 646 (52.3%) 498 (40.3%) 91 (7.4%)
21111CRT
CC CT TT
Atopy 478 (67.3%) 203 (28.6%) 29 (4.1%) 0.614 0.907 0.880
Control 805 (66.2%) 360 (29.6%) 51 (4.2%)
R130Q
RR RQ QQ
Atopy 364 (47.5%) 334 (43.5%) 69 (9%) 0.631 0.891 0.853




Atopy 606 (82.6%) 126 (17.2%) 2 (0.2%) 0.031 0.857 0.043




Atopy 543 (71.3%) 206 (27.1%) 12 (1.6%) 0.048 0.212 0.029
Control 972 (75.4%) 286 (22.2%) 30 (2.4%)
H472Q
HH HQ QQ
Atopy 256 (33.7%) 355 (46.8%) 148 (19.5%) 0.559 0.698 0.827




Atopy 724 (94.4%) 43 (5.6%) 0 (0%) 0.744 – 0.748




Atopy 247 (32.8%) 351 (46.6%) 155 (20.6%) 0.845 0.555 0.767




Atopy 568 (80.8%) 120 (17.1%) 15 (2.1%) 0.076 0.129 0.028
Control 936 (77.4%) 259 (21.4%) 15 (1.2%)
*p Values for logistic analyses controlling for age, sex, a family history of allergic diseases, passive smoking history and
vaccination history.
Dominant model (AA vs AB+BB), recessive model (AA+AB vs BB) and codominant model (AA vs AB vs BB), where A is
the major frequency allele and B is the minor frequency allele.
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However, logistic regression analysis can be problematic leading
to an increase in type II errors and a decrease in power. For
example, forward selection is limited because interactions are
only tested for those variables that have a statistically
significant independent main effect. Those SNPs that have an
interaction effect but not a main effect will be missed.
Similarly, only two SNPs with the strongest evidence for an
association with asthma phenotypes were selected in previous
studies. On the contrary, MDR is able to identify evidence for
high order gene–gene interactions in the absence of statistically
significant independent main effects in diseases.2 3 No a priori
assumption was made on whether there was an interaction
between any specific combination of SNPs in this study. Along
with this, MDR effectively detected two-locus interactions
among 12 SNPs, which showed no significant association with
atopy individually after correction for multiple testing in this
study. We used 0.016 (0.05/3) as a Bonferroni-corrected p value
because we analysed our findings at each locus under three
models. The Bonferroni procedure is said to be conservative
and, thus, will be unable to detect some of the actual
differences. However, the MDR procedure in this study
evidently finds genetic effects on atopy derived by gene–gene
interactions, which is much stronger than those caused by
individual SNPs.
The results of this study are of particular interest because
previous studies have consistently reported that interactions
between IL4RA and IL13 markedly increased an individual’s
susceptibility to asthma.8 15 Recently, Chan et al,8 using MDR
analysis, showed a significant interaction between I50V in the
IL4RA gene and R130Q in the IL13 gene for asthma that were
also included for analysis in this study.8 However, like us, they
failed to demonstrate an interaction between IL4RA and IL13
for total serum IgE concentration, another important inter-
mediate phenotype of atopy. Taken together, these findings
suggest that, although atopy is an important risk factor,
additional or different genetic factors are needed for the
development of asthma.
This study gives a new insight in the genetic basis for atopy—
that is, a significant interaction between V297I in the KDR gene
and 2308GRA in the TNF gene. VEGF was originally described
as a vascular permeability factor because of its ability to generate
tissue oedema, and subsequently it was found to be a
multifunctional angiogenic regulator that stimulates epithelial
cell proliferation, blood vessel formation and endothelial cell
survival.33 VEGF receptor 2 is a major VEGF signalling receptor.33
The ability of cockroach antigen to directly stimulate epithelial
VEGF34 may account for the impressive levels of sensitisation
that are caused by even low-level exposure to this antigen.35
Moreover, our previous study demonstrated that V297I causing
amino acid change in regions in the KDR gene which is essential
for maintaining the high association rate with VEGF and
retention of the VEGF on the receptor, was significantly
associated with the prevalence of atopy.26 It is possible that
VEGF contributes to the proclivity of individuals to become
sensitised to respiratory antigens, and thus genetic variation in
the KDR gene may have effects on the development of atopy.
Tumour necrosis factor (TNF)a is a potent proinflammatory
cytokine that is thought to be associated with a predisposition to
atopy.36 During early maturation of the infant’s immune system,
TNFa might be produced by antigen-presenting cells such as
monocytes–macrophages, dendritic cells37 and mast cells,38
playing an important role in the interactions between innate
and adaptive immunity. Innate immune cytokines, such as
TNFa, are likely to be involved in priming the adaptive immune
humoral responses. Notably, recent evidence has linked TNFa to
the development of allergic rhinitis in mice.39 Interestingly, it
has been shown that TNFa and VEGF react with each other in
an inflammatory site; TNFa induces VEGF40 and vice versa.41
Collectively, TNF and KDR may synergistically influence the
development of atopy through gene–gene interaction.
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Figure 1 Distribution of high-risk and low-risk genotypes in the best two-
locus model. This summary of the distribution shows high-risk (dark
shading) and low-risk (light shading) genotypes associated with atopy in
the two-locus interaction detected by multifactor dimensionality reduction
analysis. The percentage of participants with atopy (left black bar in boxes)
and control subjects (right hatched bar in boxes) is shown for each two-
locus genotype combination. The white boxes are unclassified. KDR, kinase
insert domain-containing receptor; TNF, tumour necrosis factor.
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